drugset
Drugs / RSV/Flu-01E
last change Apr 2024 re-read 3 minutes ago

RSV/Flu-01E

Vaccine

Developed for
respiratory syncytial virus infectious disease
Investigated by
Pavlov First Saint Petersburg State Medical University · Research Institute of Influenza, Russia · St. Petersburg City Polyclinic No. 34

Trials 1

today NCT06890429 · Ph 2
202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT06890429 Dec 2023 → Jan 2024 respiratory syncytial virus infectious disease Research Institute of Influenza, Russia Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as RSV/Flu-01E ClinicalTrials.gov intervention name — accepted as the source's own label NCT06890429 ↗
Modality Vaccine “Single dose of RSV/Flu-01E vector vaccine” NCT06890429 ↗
Route Intranasal “single intranasal injection of RSV/Flu-01E vaccine” NCT06890429 ↗